NSE:ASTRAZEN
AstraZeneca Pharma India Limited
- Stock
Last Close
5,332.25
26/04 09:59
Market Cap
157.97B
Beta: 0.39
Volume Today
11.48K
Avg: 4.82K
PE Ratio
108.89
PFCF: 7,021.31
Dividend Yield
0.24%
Payout:0%
Mar '14 | Mar '15 | Mar '16 | Mar '17 | Mar '18 | Mar '19 | Mar '20 | Mar '21 | Mar '22 | Mar '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
revenue | 4.74B - | 4.69B 0.99% | 5.26B 12.24% | 5.40B 2.49% | 5.71B 5.82% | 7.28B 27.54% | 8.32B 14.22% | 8.09B 2.79% | 8.06B 0.37% | 10.03B 24.50% | |
cost of revenue | 1.80B - | 2.03B 12.65% | 2.13B 4.86% | 2.02B 5.15% | 2.24B 10.75% | 2.70B 20.61% | 3.34B 24.01% | 3.31B 1.15% | 3.57B 8.14% | 4.58B 28.04% | |
gross profit | 2.94B - | 2.66B 9.37% | 3.14B 17.87% | 3.38B 7.67% | 3.47B 2.88% | 4.59B 31.99% | 4.97B 8.46% | 4.78B 3.90% | 4.48B 6.25% | 5.45B 21.68% | |
selling and marketing expenses | 454.97M - | 666.19M 46.43% | 728.16M 9.30% | 544.11M 25.28% | 728.10M 33.82% | 798M 9.60% | 557.60M 30.13% | 452.10M 18.92% | 507.20M 12.19% | 597.42M 17.79% | |
general and administrative expenses | 172.18M - | 176.87M 2.72% | 160.98M 8.98% | 164.95M 2.47% | 124.20M 24.70% | 235.70M 89.77% | 273.50M 16.04% | 271.10M 0.88% | 247.50M 8.71% | 299.30M 20.93% | |
selling general and administrative expenses | 627.15M - | 843.06M 34.43% | 889.14M 5.47% | 709.06M 20.25% | 852.30M 20.20% | 1.03B 21.28% | 831.10M 19.60% | 723.20M 12.98% | 754.70M 4.36% | 597.42M 20.84% | |
research and development expenses | 227M - | 287.60M 26.70% | 391.90M 36.27% | 591.60M 50.96% | |||||||
other expenses | 10.39M - | 6.72M 35.35% | 9.45M 40.72% | 3.96M 58.12% | 4.80M 21.28% | 2M 58.33% | 3.12B 155,765% | 2.89B 7.15% | 3.03B 4.69% | 4.34B 43.35% | |
cost and expenses | 4.97B - | 4.92B 0.92% | 5.27B 7.11% | 5.12B 2.89% | 5.37B 4.88% | 6.72B 25.14% | 7.29B 8.54% | 6.92B 5.06% | 7.36B 6.31% | 9.52B 29.33% | |
operating expenses | 3.17B - | 2.89B 8.64% | 3.14B 8.69% | 3.10B 1.36% | 3.13B 1.05% | 4.02B 28.38% | 3.95B 1.84% | 3.62B 8.38% | 3.78B 4.62% | 4.94B 30.55% | |
interest expense | 11.40M - | 10.90M 4.39% | 9.50M 12.84% | 6.33M 33.35% | |||||||
ebitda | -291.00M - | -47.33M 83.73% | 166.98M 452.77% | 439.14M 162.99% | 506.90M 15.43% | 712.40M 40.54% | 1.33B 87.25% | 1.46B 9.55% | 984.10M 32.66% | 1.11B 12.56% | |
operating income | -225.97M - | -262.61M 16.21% | -6.87M 97.38% | 196.70M 2,964.22% | 341.30M 73.51% | 563.80M 65.19% | 1.15B 103.65% | 1.26B 10.08% | 814.60M 35.55% | 945.09M 16.02% | |
depreciation and amortization | 101.25M - | 152.81M 50.93% | 174.26M 14.04% | 158.26M 9.18% | 147.40M 6.86% | 149.20M 1.22% | 185.80M 24.53% | 197.50M 6.30% | 169.50M 14.18% | 162.60M 4.07% | |
total other income expenses net | 54.21M - | 64.50M 18.99% | 135.35M 109.83% | 96.70M 28.55% | 162.90M 68.46% | -8.50M 105.22% | 7M 182.35% | 15.80M 125.71% | 395.96M 2,406.07% | ||
income before tax | -208.40M - | 57.64M 127.66% | 332.05M 476.11% | 438M 31.91% | 726.70M 65.91% | 1.14B 56.83% | 1.27B 11.51% | 830.40M 34.66% | 1.34B 61.49% | ||
income tax expense | 5.09M - | 62.46M 1,127.28% | 5.05M 91.92% | 87.63M 1,636.34% | 178.90M 104.16% | 182.20M 1.84% | 417.60M 129.20% | 337.90M 19.09% | 214.40M 36.55% | 348.12M 62.37% | |
net income | -5.09M - | -208.40M 3,994.91% | 52.59M 125.24% | 244.42M 364.77% | 259.10M 6.00% | 544.50M 110.15% | 722.10M 32.62% | 933M 29.21% | 616M 33.98% | 992.90M 61.19% | |
weighted average shs out | 25M - | 25M 0% | 25M 0% | 25M 0% | 25M 0% | 25M 0% | 25M 0% | 25M 0% | 25M 0% | 25M 0% | |
weighted average shs out dil | 25M - | 25M 0% | 25M 0% | 25M 0% | 25M 0% | 25M 0% | 25M 0% | 25M 0% | 25M 0% | 25M 0% | |
eps | -0.20 - | -8.34 4,070.00% | 2.10 125.18% | 8 280.95% | 10.36 29.50% | 21.78 110.23% | 28.88 32.60% | 37.32 29.22% | 24.64 33.98% | 39.72 61.20% | |
epsdiluted | -0.20 - | -8.34 4,070.00% | 2.10 125.18% | 8 280.95% | 10.36 29.50% | 21.78 110.23% | 28.88 32.60% | 37.32 29.22% | 24.64 33.98% | 39.72 61.20% |
All numbers in INR (except ratios and percentages)